Historia de los glucocorticoides

Estralgo, 1963, 433 Thorn, 1951 Stoll, 1953 Ingle D. Edward C. Kendall (1866-1972) Nat Acad of Sciences, Washington D.C. pp. 246-290. Iglesias Gamarra Antonio. Historia del Lupus. Panamericana. Formas e impresos Primera edición agosto 2003, pp. 503-513. Hench, 1949, Effect of a hormone of the adrenal cortex (17 Hydroxy – 11 Dehicrocosticosterone Compound E) and of pituitary adrenocorticotropic hormone on Rheumatoid Arthritis: Preliminary Report, Proc Staff Meet Mayo Clinic, 24, 181 Hench, 1952, The Effect of Cortisone and of ACTH on rheumatoid arthritis and rheumatic fever, 131 Hench, 1953, A Reminiscence of certain events before, during, and after the discovery of cortisone, Minn Med, 36, 705 Ingle, 1953 Hench, 1950, Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions: A Study in Clinical Physiology, Arch Inter Med, 85, 545, 10.1001/archinte.1950.00230100002001 Smyth, 1985 Polley, 1985, 9 Hench, 1952, The Reversibility of Certain rheumatic and nonrheumatic conditions by the use of cortisone or of the pituitary adrenocorticotropic hormone, Ann Inter Med, 36, 1, 10.7326/0003-4819-36-1-1 Hench, 1951, 195 Polley, 1976, Behind the scenes with cortisone and ACTH, Mayo Clinic Proc, 51, 471 Polley, 1970, Evolution of Ssteroids and their value in the control of rheumatic disease, Mayo Clin Proc, 45, 1 Kendall, 1950, Cortisone, Ann Int Med, 33, 787, 10.7326/0003-4819-33-4-787 Hollander, 1951, Hydrocortisone and cortisone iInjected into arthritic joints: Comparative Effects of and use of Hydrocortisone as Local Anti-Arthritic Agent, JAMA, 147, 1629, 10.1001/jama.1951.03670340019005 Bunim, 1955, Studies on metacostandrolone and metacostandracin in rheumatoid arthritis, JAMA, 157, 311, 10.1001/jama.1955.02950210007003 Kunkel, 1964, Autoantiboides and disease, AV Immunol, 4, 351 Elkinton, 1949, Effects of pituitary adrenocorticotropic hormone (ACTH) therapy, JAMA, 141, 1279 Grace, 1949, Remission of disseminated lupus erythematosus induced by adrenocorticotrophin, Proc Soc Exp Biol Med, 72, 563, 10.3181/00379727-72-17499 Harvey, 1950, Observations on effect of adrenocorticotropic hormone (ACTH) on disseminated lupus erythematosus, drug hypersensitivy reactin; and chronic bronchial asthma, Trans Amer Clin. Climat. Assn, 61, 221 Thorn, 1949, Studies on the relation of pituitary – adrenal function to rheumatic disease, New Eng J. Med, 241, 529, 10.1056/NEJM194910062411406 Brunsting, 1950, Effects of cortisone on acute disseminated lupus erythematosus, Proc Staff Meet Mayo Clin, 25, 479 Soffer, 1950, Use of cortisone and adrenocorticotropin in disserminated lupus erythematosus, Arch Int Med, 86, 558, 10.1001/archinte.1950.00230160070006 Soffer, 1948, Effects of anterior pituitary adrenocorticotropic hormone (ACTH) in myastenia gravis with tumor of thymus, J. Mt. Sinai Hosp, 15, 73 Soffer, 1952, Corticotropin and cortisone in acute disseminated lupus erythematosus, JAMA, 149, 1002, 10.1001/jama.1952.02930280024007 Baehr, 1950, Treatment of disseminated lupus erythematosus with cortisone and adrenocorticotropin, Bull New York Acad Med, 26, 229 Baehr, 1950, The Influence of cortisone and adrenocorticotropin in disseminated lupus erythematosus, Tr. A. Am Physicians, 63, 89 Soffer, 1951, 2, 680 Soffer, 1954, Treatment of acute disseminated lupus erythematosus with corticotropin and cortisone AMA, Arch Int Med, 93, 503, 10.1001/archinte.1954.00240280023003 Soffer, 1955, The Effect of corticotropin and adrenal steroid on the management of acute disseminated lupus erythematosus, Ann New York Acad Sci, 61, 418, 10.1111/j.1749-6632.1955.tb42492.x Muehrcke, 1957, Lupus Nephritis: A Clinical and pathologic study based on renal biopsies, Medicine, 36, 1 Conn, 1948, Production of temporary diabetes mellitus in man with pituitary aadrenocorticotrophic hormone: relation to uric acid metabolism, J. Lab. Clin Med, 33, 651 Carey, 1950, Effect of adrenocorticotropin hormone (ACTH) and cortisone on course of disseminated lupus eryhematosus and periarteritis nodosa, Bull Johns Hopkins Hosp, 87, 425 Reiner, 1950, Effect of Cortisone and adrenacorticotropin therapy on serum proteins in disseminated lupus erythematosus, Proc Soc Exp Biol Med, 74, 529, 10.3181/00379727-74-17962 Hoefer, 1950, The Effects of pituirary adrenocorticotropin hormone (ACTH) Therapy: electroencephalographic and neuropsychiatric changes in fifteen patients, JAMA, 143, 620, 10.1001/jama.1950.02910420008003 Woodbury, 1950, Antagonism of adrenocorticotropic hormone and adrenal cortical extract desoxycorticosterone: electrolytes and electroshock threshold, Am J Physiol, 160, 217, 10.1152/ajplegacy.1950.160.2.217 Vaillancourt, 1951, Absence of analgesia during induced hyperadrenalism, Proc Soc Exp Biol Med, 78, 383, 10.3181/00379727-78-19080 Robinson, 1951, 2, 49 Vaughan, 1951, The Response of serum gamma globulin level and complement titer to adrenocorticotropin hormone (ACTH) therapy in lupus erythematosus disseminatus, J Lab Clin Med, 37, 698 Boas, 1951, The Effect of ACTH and cortisone on the serum hexosamine in SLE, J Clin Endocrinol, 11, 39, 10.1210/jcem-11-1-39 Ransohoff, 1951, 1, 160 Eliel, 1951, Excesive losses of sodium, chloride and water after administration of cortisone or ACTH suggesting adrenoscortical insufficiency (Abst.), J Clin Investigation, 30, 637 Heller, 1951, Effect of cortisone in glomerulonephrits and the nephropathy of disseminated lupus erythematosus, Am J Med, 10, 520, 10.1016/0002-9343(51)90319-1 Dorfman, 1951, Status Epilepticus coincident with use of pituitary adrenocorticotropic hormone; Report of Three Cases, JAMA, 146, 25, 10.1001/jama.1951.03670010029008 Haserick, 1951, ACTH and cortisone in acute crisis of systemic lupus erythematosus, JAMA, 146, 643, 10.1001/jama.1951.63670070003009a Dubois, 1952, Corticotropin and cortisone treatment for systemic lupus erythematous, JAMA, 149, 995, 10.1001/jama.1952.02930280017006 Klemperer, 1949, Pathology of disseminated lupus erythematous, and evaluation of Osler‘s contributions, Bull Johns Hopkins Hosp, 85, 47 Tumulty, 1949, The clinical course of disseminated lupus erythematosus: An evaluation of Osler's contributions, Bull Johns Hopkins Hosp, 85, 47 Shearn, 1952, Disseminated lupus erythematosus; analysis of 34 cases, Arch Inter Med, 90, 790, 10.1001/archinte.1952.00240120065007 Harvey, 1954, Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 Cases, Medicine, 33, 291, 10.1097/00005792-195412000-00001 Irons, 1952, ACTH and cortisone in diffuse collagen disease and chronic dermatosis Differential therapeutic effects, JAMA, 145, 861, 10.1001/jama.1951.02920300001001 Armas-Cruz, 1952, Cortisona en el lupus eritematoso generalizado, Rev Med de Chile, 80, 442 Pollak, 1961, Effect of large doses of prednisone on the renal lesions and life Span of patients with lupus glomerulonephritis, J. Lab Clin Med, 57, 495 Ackerman, 1968, Adrenocortical responsiveness after alternate – day corticosteriod therapy, N. Engl J Med, 278, 405, 10.1056/NEJM196802222780801 Drinkard, 1970, Azathiporine and predsisone in the treatment of adults with lupus nephritis Clinical histological and immuological change with therapy, Medicine, 49, 411, 10.1097/00005792-197009000-00004 Cameron, 1970, Treatment of lupus nephritis with ciclophosmamide, Lancet, 2, 846 Hadidi, 1970, Ciclophosphamide in systemic lupus erythematosus, Ann Rheum Dis, 29, 673, 10.1136/ard.29.6.673 Shelp, 1971, Effect of azathioprine on renal histology and function in lupus nephritis, Arch Intern Med, 128, 566, 10.1001/archinte.1971.00310220074008 Sztejnbok, 1971, Azathioprine in the treatment of systemic lupus, erythematosus: A controlled study, Arthritis Rheum, 14, 639, 10.1002/art.1780140511 Steinberg, 1971, Cyclophosphamide in lupus nephritis: A controlled trial, Ann Inter Med, 75, 165, 10.7326/0003-4819-75-2-165 Boland, 1962, Clinical comparison of the new-antiinflamatory corticosteroids, Ann Rheum Dis, 21, 176, 10.1136/ard.21.2.176 Lieberman, 1953, Recent trend in the biochemistry of steriod hormones, Pharm Rev, 2, 285 Axelrod, 1976, Glucocorrticoid Therapy, Medicine, 55, 39, 10.1097/00005792-197601000-00003 Steroid Axelrod, 1981, 822 Freyberg, 1956, Corticotropina, cortisona e hidrocortisona Thorn, 1950, Medical Progress. The Clnical Usefulness of ACTH and Cortisone, New Engl J Med, 242, 824, 10.1056/NEJM195005252422105 Ropes, 1964, Observations on the natural course of disseminated lupus erythematosus, Medicine, 43, 387, 10.1097/00005792-196405000-00016 Waugh, 1945, Monoarticular Osteoarthritis of the hip. Treatment by Acid Injection, Brit Med J, 1, 873, 10.1136/bmj.1.4407.873 Mawson, 1946, Treatment of osteoarthritis by lactic acid iInjection, Brit Med J, 2, 691, 10.1136/bmj.2.4479.691 Walton, 1970, Alternate-day vs. shorter internal steroid administration, Arch Inter Med, 126, 601, 10.1001/archinte.1970.00310100047003 Dale, 1974, Alternate-Day Prednisone: Leukocyte Kinetics and Susceptibility to Injection, N Engl J Med, 291, 1154, 10.1056/NEJM197411282912203 Ackerman, 1968, Adrenocortical responsiveness after Alternate-day corticosteroid therapy, N Engl Med, 278, 405, 10.1056/NEJM196802222780801 Cathcart, 1976, Beneficial effects of methylprednisolone ‘pulse’ therapy in diffuse proliferative lupus nephritis Lancet, 24, 163 Perez, 1981, Effect of high-dose methylprednisolone infusion on polymorphonuclear leukocyte function in patients with systemic lupus erythematosus, Arthritis Rheum, 24, 641, 10.1002/art.1780240502 Boghossian, 1984, Effect of high – dose methylprednisolone therapy of phagocyte function in systemic lupus erythematosus, Ann Rheum Dis, 43, 541, 10.1136/ard.43.4.541 Lin, 1957, Adaption op the rat liver Tyrosine – a – ketoglutarate transaminase, Biochen Biophys Acta, 26, 85, 10.1016/0006-3002(57)90057-4 Greengard, 1962, The effect of actinomycin on the substrate and hormonal induction of liver enzymes, Biochen Biophs Acta, 61, 652 Greengard, 1962, The effect of actinomycin on the substrate and hormonal induction of liver enzymes, Biochemica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects, 4, 652, 10.1016/0926-6550(62)90130-5 Pitot, 1964, Hepatoma tissue culture compared with adapting liver in vivo, Natl Cancer Inst Mongr, 13, 229 Thompson, 1966, Induction of tyrosine – a – ketoglurate transaminase by steroid hormones in a newly established tissue culture cell line, Proc Natl Acad Sci USA, 56, 296, 10.1073/pnas.56.1.296 Peterkofsky, 1967, Effects of inhibitors of nucleic acid synthesis or steroid – mediated induction of Thyrosine Aminotransferase in Hepatoma Cell Cultures, J. Mol. Biol, 30, 49, 10.1016/0022-2836(67)90242-2 Peterkofsky, 1968, Evidence for the steroid induced accumulation of tyrosine aminotranferense messenger RNA in the absence of protein Synthesis, Proc Natl Acad Sci USA, 60, 222, 10.1073/pnas.60.1.222 Munck, 1968, Specific and nonspecific physiocochemical interactions of glucocorticoids and related steroid with rat thymus cells in vitro, J. Biol Chem, 253, 55 Schaumburg, 1968, Specificity and thermodynamic properties of the corticosteroid binding to a receptor of rat thymocytes in vitro, Bicohen Biophys Acta, 170, 172, 10.1016/0304-4165(68)90171-2 Johnson, 1982, Glucosteroid hormone action: a mechanism involving nuclear and non – nuclear pathways, Br J Dermatl, 107, 6, 10.1111/j.1365-2133.1982.tb01026.x Johnson, 1979, B axter JD. Stimulation and inhibition of cellular functions by glucocorticoids: correlations with rapid Influences on chromatin structures, J Biol Chem, 524, 77 Johnson, 1978, Regulation of gene expression by glucocorticoids: early effects preserved in isolated chromatin, J. Biol Chem, 253, 1991, 10.1016/S0021-9258(19)62345-8 Baxter, 1970, The relationship between glucocorticoid binding and tyrosine aminotransferense induction in hepatoma tissue culture cell, Proc Natl Acad Sci USA, 65, 709, 10.1073/pnas.65.3.709 Baxter, 1971, Specific cytoplasmic glucocorticoid hormone receptors in hepatoma tissue culture cells, Proc Natl Acad Sci USA, 68, 932, 10.1073/pnas.68.5.932 Jensen, 1968, The two-step mechanism for the interaction of estradiol with rat uterus, Proc Natl Acad Sci USA, 59, 632, 10.1073/pnas.59.2.632 Fang, 1971, Steroid and Tissue Specific Retention of a 17 β– Hydorxy – 5 α – Androstan – 3 – One Protein Complex by the Cell Nuclei of Ventral Prostate, J. Biol Chem, 246, 16, 10.1016/S0021-9258(18)62526-8 O’Malley, 1971, Mechanisms of action of steroid hormones, N. Engl. J Med, 284, 370, 10.1056/NEJM197102182840710 Ballard, 1974, Cytoplasmic receptors for glucocorticoids: general presence in responsive mammalian tissues, Endocrinol, 94, 998, 10.1210/endo-94-4-998 Baxter, 1972, Role of DNA and specific cytoplasmic receptor in glucocorticoid action, Proc Natl Acad Sci USA, 69, 1982, 10.1073/pnas.69.7.1892 Hirata, 1979, Identification of several species of phospholipase inhibitory protein(S) by radioinmunoassay for lipomodullin, Nature, 278, 456 Hirata, 1980, Phrospholipase Ax inhibitory protein in rabbit neutrophile induced by glucocorticoids, Proc Natl Acad Sci U.S.A, 77, 2533, 10.1073/pnas.77.5.2533 Hirata, 1981, Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases, Proc Natl Acad Sci USA, 78, 3190, 10.1073/pnas.78.5.3190 Hirata, 1981, The regulation of lipomodulin, a phospholipase inhibitory protein in rabbit neutrophil, by phosphorylatin, J. Biol Chem, 256, 7730, 10.1016/S0021-9258(18)43335-2 Flower, 1979, Anti inflamatory steroides induce biosynthesis of a phospholipase A2 inhibitor which prevent protaglandin generation, Nature, 278, 456, 10.1038/278456a0 Blackwell, 1980, Macrocortin: A Polypeptide causing the anti-phospholipase effed Of glucocorticoids, Nature, 278 Scheinman, 1995, Role of transcriptional activation of IkBα bol in medication of immunosupression by glucocorticoids, Science, 270, 283, 10.1126/science.270.5234.283 Auphan, 1995, inmunosupression by glucocorticoids: inhibition of NF – KB activity through induction of IkBα synthesis, Science, 270, 286, 10.1126/science.270.5234.286 Boumpas, 1993, Glucocorticoid therapy for immune – mediated diseases: Basic and clinical correlates, Ann Inter Med, 119, 1198, 10.7326/0003-4819-119-12-199312150-00007 Rutgeerts, 1999, Deflazacort. an alternative to prednisolone?, Drug ther Bull, 37, 57, 10.1136/dtb.1999.37857 Rutgeerts P, Lofberg R, Malchow H, et al. A comparision of budesonide with prednisolone for active Crohn's disease. N Eng J Med 331: 842-845. Lu, 2004, The origin and functions at multiple human glucocorticoid receptor isoforms, Ann NY Acad Sci, 1024, 102, 10.1196/annals.1321.008 Rhen, 2005, Antiinflammatory Action of Glucocorticoids New mechanisms for old Drugs, N Engl J Med, 353, 1711, 10.1056/NEJMra050541 Straub, 2007, Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management, Arthritis Rheum, 56, 399, 10.1002/art.22368 Haus, 2007, Chronobiology in the endocrine system, Adv Drug Deliv Rev, 59, 985, 10.1016/j.addr.2007.01.001 Tharp, 1965, Rhytmic changes in rare of the mammalian heart an heart cells during prolonged Isolation Comp, Bioch Physiol, 14, 255 Andrew, 1964, Circadian Metabolic Patterns In Cultured Hamster Adrenal Glands, Comp Biochem Physiol, 11, 393, 10.1016/0010-406X(64)90006-4 Andrews, 1917, Circadian rhythms in adrenal organ cultures, Gegenbaurs Morphologisches Jahrbuch, 117, 89 Whitmore, 1998, Zebrafish Clock rhythmic expression reveals independent peripheral circadian oscillators, Nature Neuroscience, 1, 701, 10.1038/3703 Engeland, 2005, Neural circuitry in the regulation of adrenal corticosterone rhythmicity, Endocrine, 28, 325, 10.1385/ENDO:28:3:325 Edwards, 1987, The effect of splanchnic nerve section on the sensitivity of the adrenal cortex to adrenocorticotrophin in the calf, J Physiol, 390, 23, 10.1113/jphysiol.1987.sp016683 Walker, 1995, Chemical sympathectomy and maternal separation affect neonatal stress responses and adrenal sensitivity to ACTH, Am. J Physiol l, 268, R1281 Engeland, 1989, Splanchnic nerve stimulation modulates steroid secretion in hypophysectomized dogs, Neuroendocrinology, 50, 124, 10.1159/000125211 Klein, 1991 Berson, 2007, Phototransduction in ganglion-cell photoreceptors, Pflu Gers Archiv, 454, 849, 10.1007/s00424-007-0242-2 Hankins, 2008, Melanopsin: an exciting photopigment, Trends in neurosciences, 31, 27, 10.1016/j.tins.2007.11.002 Roenneberg, 1997, Twilight times: light and the circadian system Photochem, Photobiol, 66, 549, 10.1111/j.1751-1097.1997.tb03188.x Provencio, 1998, Melanopsin: An opsin in melanophores, brain, and eye, Proc Natl Acad Sci, 95, 340, 10.1073/pnas.95.1.340 Buijs, 1993, Suprachiasmatic nucleus lesion increases corticosterone secretion, American Journal of Physiology, 264, 1186 Kalsbeek, 1992, Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release, Brain Research, 580, 62, 10.1016/0006-8993(92)90927-2 Balsalobre, 2002, Clock genes in mammalian peripheral tissues, Cell Tissue Res, 309, 193, 10.1007/s00441-002-0585-0 Konopka, 1971, Clock mutants of Drosophila melanogaster, Proc Natl Acad Sci U S A, 68, 2112, 10.1073/pnas.68.9.2112 Feldman, 1973, Isolation of circadian clock mutants of Neurospora crassa, Genetics, 75, 605, 10.1093/genetics/75.4.605 Welsh, 1995, Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms, Neuron, 14, 697, 10.1016/0896-6273(95)90214-7 Roenneberg, 2002, ‘What watch?.such much!’ Complexity and evolution of circadian clocks, Cell and Tissue Research, 309, 3, 10.1007/s00441-002-0568-1 Kowanko, 1982, Domiciliary self measurement in the rheumatoid arthritis and the demonstration of circadian rhythmicity, Ann Rheum Dis, 41, 453, 10.1136/ard.41.5.453 Cutolo, 2005, Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison, Ann Rheum Dis, 64, 212, 10.1136/ard.2004.023416 Petrovsky, 1998, The chronobiology of human cytokine production, Int Rev Immunol, 16, 635, 10.3109/08830189809043012 Salvarani, 2008, Polymyalgia rheumatica and giant-cell arteritis Seminar, Lancet, 372, 234, 10.1016/S0140-6736(08)61077-6 Cutolo, 2005, Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison, Ann Rheum Dis, 64, 212, 10.1136/ard.2004.023416 Meyer-Hermann, 2009, Mathematical modeling of the circadian rhythm of key neuroendocrine-immune system players in rheumatoid arthritis: a systems biology approach, Arthritis Rheum, 60, 2585, 10.1002/art.24797 Hoes, 2007, EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases, Ann Rheum Dis, 66, 1560, 10.1136/ard.2007.072157 Buttgereit, 2008, Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomized controlled trial, Lancet, 371, 205, 10.1016/S0140-6736(08)60132-4 Buttgereit, 2005, Optimised glucocorticoid therapy: the sharpening of an old spear, Lancet, 375, 801, 10.1016/S0140-6736(05)71005-9 Cutolo, 2008, Circadian rhytms of nocturnal hormones in rheumatoid arthritis: translation from bench to bed side, Ann Rheum Dis, 67, 905, 10.1136/ard.2008.088955 Buttgereit, 2008, Arthritis and endogenous glucocorticoids: the emerging role of the 11β HSD enzymes, Ann Rheum Dis, 67, 1201, 10.1136/ard.2008.092502